Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome-Reference-Cited by-同舟云学术

Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome

Published:2020-07-15 Issue: Volume:26 Page:
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Liu Weiwen¹,Xu Huihong²,Ying Xihui¹,Zhang Dengke¹,Lai Linqiang¹,Wang Linyou³,Tu Jianfei¹,Ji Jiansong¹

Affiliation:

1. Department of Radiology, Lishui Central Hospital/Key Laboratory of Imaging Diagnosis and Minimally Invasive Interventional Research of Zhejiang, Lishui, Zhejiang, China (mainland)

2. Department of Radiology, Qingtian County People’s Hospital of Lishui City, Lishui, Zhejiang, China (mainland)

3. Department of Radiology, Taizhou Municipal Hospital of Zhejiang Province, Taizhou, Zhejiang, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locoregional interventional therapy for hepatocellular carcinoma: radiologic and clinical factors predictive of untreatable progression and time to untreatable progression;Frontiers in Pharmacology;2024-07-23

2. Evaluation and Management of Unresectable Hepatocellular Carcinoma: Multidisciplinary Indian Consensus Statements from a Delphi Panel;South Asian Journal of Cancer;2024-07-22

3. How AI and Robotics Will Advance Interventional Radiology: Narrative Review and Future Perspectives;Diagnostics;2024-06-29

4. Radiofrequency ablation combined with transcatheter arterial chemoembolization for recurrent liver cancer;World Journal of Gastrointestinal Surgery;2024-06-27

5. Radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma meeting Milan criteria: a focus on tumor progression and recurrence patterns;Frontiers in Oncology;2024-05-01